Shuang Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shuang Gao has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Jianxin Guo
College of Integrated Chinese and Western Medicine, Hebei Medical University, Shijiazhuang 050017, China
1 shared publication - Jing Li
College of Integrated Chinese and Western Medicine, Hebei Medical University, Shijiazhuang 050017, China
1 shared publication - Ming Huang
College of Integrated Chinese and Western Medicine, Hebei Medical University, Shijiazhuang, 050017, China
1 shared publication - Yu Wang
College of Integrated Chinese and Western Medicine, Hebei Medical University, Shijiazhuang, 050017, China
1 shared publication - Zhongbing Wu
College of Integrated Chinese and Western Medicine, Hebei Medical University, Shijiazhuang 050017, China
1 shared publication
Latest Publications
- Open Access
- 13 October 2024
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 46 (10) , 11349-11358
Knockdown of Gas6 Exerts Anti-Esophageal Cancer Effects by Inhibiting the PI3K/AKT Pathway
Esophageal squamous cell carcinoma (ESCC) is a malignant tumor of the digestive tract with strong migratory and invasive abilities. Gas6 is closely associated with the progression of many malignant tumors; however, the role of Gas6 in the progression of esophageal cancer is unclear. Here, we report that the knockdown of Gas6 inhibited esophageal cancer cell proliferation, migration, and invasion. In addition, Gas6 knockdown downregulated the levels of P-PI3K and P-AKT. Taken together, the findings confirm that Gas6 knockdown can inhibit esophageal cancer progression and can exert anti-tumor effects on esophageal cancer through the PI3K/AKT pathway.
- 13 October 2024
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 46 (10) , 11349-11358
Open AccessKnockdown of Gas6 Exerts Anti-Esophageal Cancer Effects by Inhibiting the PI3K/AKT Pathway
Esophageal squamous cell carcinoma (ESCC) is a malignant tumor of the digestive tract with strong migratory and invasive abilities. Gas6 is closely associated with the progression of many malignant tumors; however, the role of Gas6 in the progression of esophageal cancer is unclear. Here, we report that the knockdown of Gas6 inhibited esophageal cancer cell proliferation, migration, and invasion. In addition, Gas6 knockdown downregulated the levels of P-PI3K and P-AKT. Taken together, the findings confirm that Gas6 knockdown can inhibit esophageal cancer progression and can exert anti-tumor effects on esophageal cancer through the PI3K/AKT pathway.